The Vanderbilt University (VU) Center for Infectious Disease Research in Zambia (CIDRZ) AITRP, formerly the VU-University of Alabama at Birmingham AITRP, seeks renewal of its grant, now in its tenth year due to an NIH-initiated one-year extension. We contribute research training to both institutional and individual biomedical and behavioral research capacities focused on HIV-related research in both prevention and care. The VU-CIDRZ training partnership with our international collaborators is designed to train foreign scientists and key research support staff to conduct independent research and training in their home countries, as well as perform at an internationally credible level in collaborations with local and foreign scientists. We now seek to renew our AITRP with a continued focus on Zambia (since 1998), Pakistan (since 1994), India (since 2000), China (since 2000), and our newest partnership in Mozambique (VU training partnership since 2006 and developmental AITRP engagement since 2007). We have completed our older training commitments in Mongolia, Jamaica, and Russia and will complete our training commitments for Bangladesh upon the graduation of a current doctoral training (anticipated in 2011). We have restricted our AITRP training partnerships to five focus cities in order not to dilute our impact to where we have funded overseas research and strong research training partners. At the same time, we have leveraged support in each of the five venues such that our AITRP resources will go much further than permitted by the grant's funding alone. We will continue to provide a diverse portfolio of long, medium, and short-term training options. To date 58 trainees have received graduate degrees, 97% of whom have returned to work in their home countries, 8 are currently in degree programs and over 2,000 have been trained through our in-country advanced short- courses. We believe VU remains an ideal university partner for this initiative for several significant reasons The migration of the training program to VU offers the opportunity for trainees to receive the absolute highest quality of graduate training and exposure to innovative HIV/AIDS/STD/TB related research, resources, and faculty mentors. The program is uniquely positioned within the infrastructure of the VU Institute for Global Health (VU IGH),directed by Dr. Vermund with its "center-without-walls" philosophy that nurtures noncompetitive partnerships among and within VU and with partner institutions around the globe. We feel that the innovative features of our renewal and our proven track record address the unmet needs in international AIDS training.

Public Health Relevance

(Seeinstructions): The VU-CIDRZ training partnership with our international collaborators is designed to strengthen both institutional and individual biomedical and behavioral research capacities focused on HIV-related research in both prevention and care in developing countries.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Training Grants (D43)
Project #
3D43TW001035-15S2
Application #
8848444
Study Section
Special Emphasis Panel (ZRG1-BDA-K (51))
Program Officer
Mcdermott, Jeanne
Project Start
1998-09-30
Project End
2015-03-31
Budget Start
2013-04-01
Budget End
2015-03-31
Support Year
15
Fiscal Year
2014
Total Cost
$100,000
Indirect Cost
$5,365
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Sellers, Christopher J; Lee, Hana; Chasela, Charles et al. (2015) Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: the Breastfeeding, Antiretrovirals and Nutrition study experience. Clin Trials 12:156-65
Howard, Leigh M; Tique, José A; Gaveta, Sandra et al. (2014) Health literacy predicts pediatric dosing accuracy for liquid zidovudine. AIDS 28:1041-8
Vinikoor, Michael J; Schuttner, Linnaea; Moyo, Crispin et al. (2014) Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia. AIDS Res Hum Retroviruses 30:74-7
Vermund, Sten H; Blevins, Meridith; Moon, Troy D et al. (2014) Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One 9:e110116
Sweetland, Annika C; Oquendo, Maria A; Sidat, Mohsin et al. (2014) Closing the mental health gap in low-income settings by building research capacity: perspectives from Mozambique. Ann Glob Health 80:126-33
Rathod, Sujit D; Chi, Benjamin H; Kusanthan, Thankian et al. (2014) Trends in all-cause mortality during the scale-up of an antiretroviral therapy programme: a cross-sectional study in Lusaka, Zambia. Bull World Health Organ 92:734-41
Mwanahamuntu, Mulindi H; Sahasrabuddhe, Vikrant V; Blevins, Meridith et al. (2014) Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet 126:88-9
Li, Xuefeng; Lu, Hongyan; Cox, Catherine et al. (2014) Changing the landscape of the HIV epidemic among MSM in China: results from three consecutive respondent-driven sampling surveys from 2009 to 2011. Biomed Res Int 2014:563517
Tao, Jun; Li, Ming-ying; Qian, Han-Zhu et al. (2014) Home-based HIV testing for men who have sex with men in China: a novel community-based partnership to complement government programs. PLoS One 9:e102812
Vinikoor, Michael J; Joseph, Jessica; Mwale, Jonas et al. (2014) Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia. AIDS Res Hum Retroviruses 30:949-55

Showing the most recent 10 out of 91 publications